FDA: Auvi-Q epinephrine injection recalled

Posted in Latest News on October 30, 2015.

Under a voluntary recall, Sanofi US has recalled all Auvi-Q products on the market in both 0.15 mg and 0.3 mg because of suspected device malfunctions, the FDA announced this week. The product is available to hospitals, retailers and customers.

According to the FDA announcement, the product can deliver the wrong dosage. A patient experiencing allergic reaction could die if the proper dosage is not used.



More Latest News

First Quarterly Performance Report Released for the 2019-2020 Fiscal Year
December 16, 2019

The Quarterly Performance Report for the first quarter of the 2019-2020 fiscal year is now available online. Continue reading


Annual Report & Long-Range Plan Released for the 2018-2019 Fiscal Year
October 29, 2019

The Annual Report & Long-Range Plan for the 2018-2019 Fiscal Year is now available to view online. Continue reading